Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment. - Wikidata - awgldk - TriplyDB

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment.

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment.

http://www.wikidata.org/entity/Q37562469

about

The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review Oral prolonged-release oxycodone/naloxone for managing pain and opioid-induced constipation: A review of the evidence.Absorption of ibuprofen orodispersible tablets in early postoperative phase - a pharmacokinetic study.

P2860

Q30235088-EEC75442-6D91-40C5-B4E5-D04183627C72 Q43075972-8E40F79B-665C-42BA-915A-2B702355A82B Q47240689-D49E60DA-8DE0-4069-AA44-2731D8FEED9B

P2860

Opioid-Induced Bowel Dysfunction in Patients Undergoing Spine Surgery: Comparison of Oxycodone and Oxycodone-Naloxone Treatment.

http://www.wikidata.org/entity/Q37562469

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@en

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@nl

type

label

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@en

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@nl

prefLabel

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@en

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@nl

P1433

Q37562469-A67653C9-6AD6-439C-B019-9B10816E5700

P1476

Q37562469-C112B7F5-6672-46BC-8B1C-DCE23BEF0A5B

P2093

Q37562469-18F675F0-94F3-45D7-8AEB-2D42BC7E24BF

Q37562469-39D4C9B3-97FB-498E-8D1F-AB0D560540A0

Q37562469-5BDCE167-4E85-44C4-8FEE-82FE373BBAFD

Q37562469-7B67DB0C-F0BD-4743-86D9-59C20B244949

Q37562469-9073EAAE-4946-4B6F-B30E-14DB3D7215FE

Q37562469-BD9057E3-EB44-42C5-A7D1-589398B3ABCA

Q37562469-C4715375-49B2-4F1C-9E74-4551117B36DF

P2860

Q37562469-0E357D85-A70C-4F3A-AB81-50FC58E98D7B

Q37562469-1A97C9F6-70E8-40E6-87F7-54CE23BE9E53

Q37562469-1C194B06-DA6E-4AD4-A85C-A48E1E787603

Q37562469-1EE2A194-8001-4A75-A4C2-183AEDE6FA6B

Q37562469-2284C01D-4C9D-4A51-A2E6-C1F4E38FDEEC

Q37562469-26A1D3DA-7831-49ED-AFED-8B7FFE96AB34

Q37562469-4589F584-EC35-4233-AB35-558ABB4CCB4D

Q37562469-5C2D8022-CC68-44A2-AC09-2FF0D2795629

Q37562469-5DA41DA3-F882-46AA-B3BF-849D7F1C0695

Q37562469-74FE24AA-438E-4A4C-B68B-9A944ACBB6AB

P2888

Q37562469-194D8FED-5269-4E01-91D3-D5F8D18D5A2F

P304

Q37562469-EBE2B14E-7592-426B-867B-DE6D613413B3

P31

Q37562469-D40C4B9C-A31D-4B77-8D6E-8CF0595EF254

P356

Q37562469-D3F36A01-BBF9-4C8F-B0F9-87BF78CE20B7

P407

Q37562469-D90E2196-2D2B-48F9-A237-A262824D40B3

P433

Q37562469-21773FB1-E48C-4F53-B8A1-9D416C1AE930

P478

Q37562469-44E35916-E3F3-4CBA-B388-BCAA777D6CE3

P577

Q37562469-DDDE9597-97EC-452A-B1DE-AF033E95B0F9

P698

Q37562469-8A43B0DB-84AC-48E8-99A1-696CE1E421B3

P921

Q37562469-C20B11CC-4E78-464A-9975-B6AAAC3F5A84

Q37562469-c7c7c4ef-52cf-4b9b-ad95-5112825f702c

P932

Q37562469-52F9E5BA-D573-4D0A-8DB3-F4CFEA21A437

P356

S12325-016-0456-9

P1433

Advances in Therapy

P1476

Opioid-Induced Bowel Dysfuncti ...... Oxycodone-Naloxone Treatment.

@en

P2093

Hannu Kokki

http://www.w3.org/2001/XMLSchema#string

Ira Pikkarainen

http://www.w3.org/2001/XMLSchema#string

Merja Kokki

http://www.w3.org/2001/XMLSchema#string

Moona Kuronen

http://www.w3.org/2001/XMLSchema#string

Sakari Savolainen

http://www.w3.org/2001/XMLSchema#string

Timo Nyyssönen

http://www.w3.org/2001/XMLSchema#string

Toivo Naaranlahti

http://www.w3.org/2001/XMLSchema#string

P2860

Opioids in chronic non-cancer pain: systematic review of efficacy and safety.

Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review

Incidence, prevalence, and management of opioid bowel dysfunction.

Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain.

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis.

Oxycodone for the treatment of postoperative pain.

Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery.

Opioid-induced bowel dysfunction: pathophysiology and management.

Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.

Constipation in the cancer patient: causes and management.

P2888

s12325-016-0456-9

P304

236-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-016-0456-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27921252

http://www.w3.org/2001/XMLSchema#string

P921

P932

5216064

http://www.w3.org/2001/XMLSchema#string